Efficient capital flow = efficient bioscience growth
BioOhio’s Capital Connections event will bring together experts from the Midwest for networking and discussion on strategies to ensure an efficient supply of funds to enable start-up companies to thrive in Ohio. The event will be held in Columbus on March 5th at 1:30PM.
“Ohio and the Midwest are in the midst of a drought as it relates to funding early stage bioscience companies,” said Peter Kleinhenz, Managing Director, CID Capital and BioOhio Board Member. “We’re continuing to get funding and get some companies going, but we still have this real challenge.”
Kleinhenz will moderate a panel that represents venture capitalists and other investor viewpoints to provide a candid look at the current funding landscape, a description of what programs are in place in Ohio and throughout the Midwest, and a discussion of shifts that may be needed in public policy as well as investor and entrepreneur expectations.
Capital Connections features three unique panels comprised of bioscience capital experts. The panels will draw upon the wisdom of 1) investors; 2) experts at alternative funding sources, and 3) entrepreneurial bioscience leaders, all sharing insights to those seeking to benefit from intelligent investment in Ohio bioscience organizations and technology.
Wrapping up the day is a late afternoon networking reception that will keep the exchange of information and ideas flowing between presenters, attendees and sources of capital.
Complete information and registration at: http://www.bioohio.com/events/capital-connections/
BioOhio’s President & CEO, John F. Lewis, Jr. meeting Ohio lawmakers in Washington, DC
Ironically, our “United States” are often not quite so united. That’s because each of the 50 states is naturally competitive in matters ranging from college sports (in Ohio, think football, November, and “that team up north”) to retaining businesses and especially, to attracting new companies, technologies and jobs. State borders may not be hostile, but economic realities necessitate consideration of states’ interests.
But a shared sense of purpose between state leaders of industries exists and is often unappreciated. This collaborative force will be on full display on February 26-27 when leaders of over 30 state bioscience associations convene in Washingon, DC, as part the annual AdvaMed Fly-In.
There, they’ll confer with each other and team with key bioscience industry leaders to directly advocate with US senators, congressional representatives and other important public policy leaders. A particular focus of this year’s “Fly-in” will be issues related to the medical device industry. ::read more::
Dr. John Whapham holds an iPad that can receive medical imagery and other data gathered from emergency sites. Courtesy Toledo Blade /Jetta Fraser
We all have “those days: ” too much to do, not enough time to do it, and no way to be in two places at once. But with the arrival of virtual and remote medical assistants like a telemedicine robot named Vinnie, the gap between what can be frustrating and what can be accomplished seems to be narrowing.
Dr. John Whapham of Toledo’s Mercy St. Vincent Medical Center is pushing the telemedicine envelope with the help of robotic units that can remotely monitor patients in need of acute care due to accident or a catastrophic medical event. Remote monitoring can mean earlier more responsive care – and the difference between life and death.
In fact, Mercy’s robots will soon take to the sky in medical helicopters for use moments after landing at the site of a medical emergency. An executive with the developer of the robotic device says he is unaware of remote telemedical units like Vinnie being used in such a way anywhere in the US.
See the complete story, by Marlene Harris-Taylor, in the Toledo Blade.
Tim Miller is the President & CEO of BioOhio member company Abeona Therapeutics LLC, which is developing therapies for patients with lysosomal storage diseases. Abeona’s lead therapies target the deadly childhood diseases Sanfilippo Syndrome Type A and Type B.
Visit Fresh Water, a weekly e-magazine and website focused on news in and around Cleveland for a great interview on his thoughts about being an entrepreneur and his passion for bringing new cures to those in need.
BioOhio is proud to include Tim in our upcoming Capital Connections event, where he will be speaking about alternative sources of funding, and how his company has grown.